Magnova 1000 mg/125 mg Injection
Images are for reference. Actual packaging may vary.
Vial of 1 injection • InjectionPrescription requiredSchedule H
Magnova 1000 mg/125 mg Injection
Cefepime (1000mg) + Tazobactum (125mg)
₹636.40
Vial of 1 injection • Injection
A valid prescription is required for this medicine.
1
Delivery
Safe & Secure
Easy Returns
24/7 Support
SMARTER CARE
A little guidance.
A better choice.
Haven’t found an alternative? A health advisor can help you understand what to do next.
No matching alternative found
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
Tazobactum 125 mg
+1 more active ingredient
How It Works
Cefepime binds to penicillin-binding proteins, disrupting bacterial cell wall synthesis and causing cell death.
Medicine Strength
125 mg
All Active Ingredients
Tazobactum125 mg
Cefepime1000 mg
Uses & Benefits
Medical applications
InfectionBacterialAllergySkin
Magnova 1000 mg/125 mg Injection is a combination antibiotic formulation containing Cefepime, a fourth-generation cephalosporin (1000 mg), and Tazobactam, a β-lactamase inhibitor (125 mg). This injectable preparation is indicated for the treatment of moderate to severe bacterial infections caused by susceptible organisms, including complicated urinary tract infections, intra-abdominal infections, skin and soft tissue infections, and pneumonia.
Read full descriptionShow less
Cefepime exerts its bactericidal action by inhibiting bacterial cell wall synthesis, leading to cell lysis and death, while Tazobactam enhances efficacy by inhibiting β-lactamase enzymes produced by resistant bacteria, thereby extending the spectrum of activity. Magnova is effective against a broad range of gram-positive and gram-negative pathogens, including Pseudomonas aeruginosa and Enterobacteriaceae.
The injection is administered intravenously or intramuscularly, with dosage adjustments recommended in patients with renal impairment. Common adverse effects may include gastrointestinal disturbances, hypersensitivity reactions, and transient hematologic abnormalities. Caution is advised in patients with a history of β-lactam allergy. Magnova 1000 mg/125 mg Injection should be used under strict medical supervision, with therapy guided by culture and sensitivity results to minimize the development of resistance and ensure optimal clinical outcomes.
Dosage & How to Use
How to use Magnova Injection Your doctor or nurse will give you this medicine. Kindly do not self administer.
Safety Advice
Important precautions
Side effects
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Safety Advice
Alcohol
Caution is advised when consuming alcohol with Magnova 1000 mg/125 mg Injection. Please consult your doctor.
High Risk
Pregnancy
Magnova 1000 mg/125 mg Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Medical Advice
Driving
Magnova 1000 mg/125 mg Injection may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.
Exercise Caution
Liver
Magnova 1000 mg/125 mg Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Magnova 1000 mg/125 mg Injection may not be needed in these patients. Please consult your doctor.
Regular Checkup
Breastfeeding
Magnova 1000 mg/125 mg Injection is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Consult Doctor
Kidney
Magnova 1000 mg/125 mg Injection should be used with caution in patients with kidney disease. Dose adjustment of Magnova 1000 mg/125 mg Injection may be needed. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Magnova 1000 mg/125 mg Injection
